Notes / Company

Syschem (India) Ltd.

SYSCHEM BSE 531173 ISIN INE121D01036 Pharmaceuticals

Fundamentals

Market cap: ₹211 cr
P/E: 19.29×
ROE: 0.50%
Debt / equity: 0.00
52-week range: 40.50 — 62.00

Research on Tijori Finance

Company snapshot

Syschem (India) Ltd.

Pharmaceuticals

₹206 cr

P/E 18.87×

Latest quarter · Mar 2026

Sales₹248 cr

Net profit₹2 cr

Op. margin+3.8%

EPS₹0.36

Strength & growth

Debt / equity0.00×

Current ratio1.30×

Sales CAGR+57.7%

EPS CAGR+27.3%

The timeline — 2 notes on Syschem (India) Ltd.

June 2026

03 Jun 26 · 2:30 PM IST Brief

Brief · Micro cap

Syschem hands MD role to Suninder Veer Singh, Jain stays as WTD

Promoter-group rejig at the ₹232 cr nano-cap lifts combined fixed management cost to ₹1.68 cr/year. Shareholders have to ratify via postal ballot.

May 2026

25 May 26 · 4:43 PM IST Brief

Brief · Earnings · Micro cap

Syschem profit jumps to ₹10.9 cr, but warrant conversion did the heavy lifting.

Revenue rose 70% and profit swelled over 20x, but the bottom-line number was inflated by a one-off warrant conversion. The market already knew.

Verify on exchange BSE filings for SYSCHEM NSE filings for SYSCHEM Tijori Finance company page